Abstract
Introduction Eculizumab, the anti-C5 monoclonal antibody therapeutic, has revolutionized the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) an......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
